ELND#

Related by string. * * ELND# AZD . include ELND# AZD *

Related by context. All words. (Click for frequent words.) 70 Asentar 70 lomitapide 70 Phenoptin 70 R#/MEM # 69 Bezielle 69 methylnaltrexone 69 AZILECT R 69 Fibrillex TM 69 MAGE A3 ASCI 69 Plicera 69 Panzem R 69 Traficet EN 68 elotuzumab 68 INCB# [001] 68 muraglitazar 68 Archexin 68 phase IIb clinical 68 KNS # 68 PDE4 inhibitor 68 Laquinimod 68 otelixizumab 68 YONDELIS 68 ocrelizumab 68 PS# [001] 67 PD LID 67 alvimopan 67 RhuDex ® 67 HuMax CD4 67 dirucotide 67 alvespimycin 67 Pimavanserin 67 oral prodrug 67 lixivaptan 67 AEGR 67 CDP# 67 RSD# 67 LY# [003] 67 PEG Interferon lambda 67 Golimumab 67 LAF# 67 atacicept 67 Azedra 67 Mipomersen 67 Saxagliptin 67 LymphoStat B 67 custirsen 67 Allovectin 7 R 67 JAK inhibitor 67 SRT# [003] 67 CEQ# 67 ATL# [001] 66 tezampanel 66 Bicifadine 66 CR# vcMMAE 66 Cethromycin 66 ularitide 66 Aurexis 66 Velcade bortezomib 66 ganetespib 66 tramiprosate 66 refractory gout 66 investigational compound 66 Aflibercept 66 Triolex 66 Ceflatonin 66 Phase Ib study 66 Alzhemed TM 66 ISIS # 66 danoprevir 66 BAY #-# 66 PEG SN# 66 huC# DM4 66 metaglidasen 66 E1 INT TM 66 RhuDex 66 cangrelor 66 Vilazodone 66 HQK 66 TACI Ig 66 GSK# [001] 66 ACTEMRA TM 66 ZOLINZA 65 midstage clinical 65 mertansine 65 Phase IIa clinical 65 NVA# 65 vilazodone 65 fostamatinib 65 TELINTRA 65 ASONEP 65 tanespimycin 65 #D#C# 65 lapatinib Tykerb 65 GW# [003] 65 dacetuzumab 65 forodesine 65 TRO# 65 Mylotarg 65 Tarceva TM 65 INCB# [003] 65 tecarfarin 65 HuMax CD# 65 PROMACTA 65 UPLYSO 65 Safinamide 65 TBC# 65 mapatumumab 65 metastatic hormone refractory 65 CIMZIA TM 65 Prestara 65 phase IIa clinical 65 eltrombopag 65 Pirfenidone 65 Tolvaptan 65 oral ridaforolimus 65 Zerenex 65 tocilizumab 65 riociguat 65 aflibercept 65 TOCOSOL Paclitaxel 65 Alemtuzumab 65 alemtuzumab Campath 65 talactoferrin 65 Phase Ib clinical 65 Amigal 65 orally bioavailable 65 JP-#/fipamezole 65 OXi# 65 SERMs 65 Cloretazine 65 6R BH4 65 IPL# 65 daclizumab 65 dexpramipexole 65 ELND-#/AZD-# 65 efalizumab 65 Tavocept 65 Onconase 65 LibiGel ® 65 Symadex 65 Virulizin ® 65 NGX# 65 PHX# 65 severe gastroparesis 65 proteasome inhibitor 65 Arranon 65 Dasatinib 65 anticancer compound 64 Silodosin 64 BRIM2 64 Virulizin 64 Tyrima 64 HuMax EGFr 64 NP2 Enkephalin 64 Gabapentin GR 64 phase IIb 64 brivaracetam 64 XYOTAX TM 64 R#/MEM 64 oral salmon calcitonin 64 GAMMAGARD 64 CRx 64 teplizumab 64 orBec 64 Belimumab 64 thymalfasin 64 Amrubicin 64 MDV# 64 interferon gamma 1b 64 Reverset 64 OHR/AVR# 64 rasagiline tablets 64 canagliflozin 64 tramiprosate ALZHEMED TM 64 PRT# 64 subcutaneously administered 64 Arimoclomol 64 Teriflunomide 64 Diamyd ® 64 HGS# 64 Omacetaxine 64 Panzem R NCD 64 Desmoteplase 64 CoFactor 64 Torisel 64 PREZISTA r 64 CD# monoclonal antibody 64 Nanobody 64 Rebif ® 64 GLPG# 64 Sym# 64 EndoTAG TM -1 64 Corlux 64 PRTX 64 Daclizumab 64 Perifosine 64 Natalizumab 64 Tasimelteon 64 CTAP# Capsules 64 CIMZIA ™ 64 Bortezomib 64 Heplisav 64 Sapacitabine 64 LymphoStat B belimumab 64 TREANDA 64 bicifadine 64 RG# [001] 64 desvenlafaxine 64 schizophrenia CIAS 64 GSK# [002] 64 Maribavir 64 Xanafide 64 tarenflurbil 64 ABILIFY ® 64 metastatic castration resistant 64 Serdaxin 64 ELND# AZD 64 squalamine 64 PSMA ADC 64 ancrod 64 teduglutide 64 TYKERB 64 STRIDE PD 64 PLK1 SNALP 64 favorable pharmacokinetic profile 64 safinamide 64 tafamidis 64 Rasagiline 64 Catena ® 64 Cleviprex TM clevidipine 64 axitinib 64 MEK inhibitor 64 Exelixis compounds 64 motesanib 64 galantamine 63 ADAGIO study 63 Ixempra 63 tramiprosate Alzhemed TM 63 Meets Primary Endpoint 63 CA4P 63 tremelimumab 63 AP# [003] 63 Androxal TM 63 Synavive 63 solanezumab 63 selective androgen receptor modulator 63 ONGLYZA ™ 63 Tanespimycin 63 XmAb# 63 tiapamil 63 PEG PAL 63 Dalbavancin 63 Phase Ib 63 KRN# 63 oral formulation 63 Xinlay 63 ataluren 63 laquinimod 63 PEGylated Fab fragment 63 DDP# 63 HuLuc# 63 HGS ETR1 63 aleglitazar 63 betrixaban 63 rNAPc2 63 perampanel 63 romidepsin 63 ANAVEX #-# [003] 63 Pafuramidine 63 glufosfamide 63 liprotamase 63 Gemzar ® 63 MAP# 63 Pyridorin 63 abiraterone acetate 63 Azixa 63 TELCYTA 63 dimebon 63 TG# [003] 63 Genz # 63 Zelapar 63 pralatrexate 63 ORENCIA R 63 AZD# 63 PXD# 63 oral antiviral 63 QNEXA 63 ONTAK 63 Lu AA# 63 PSN# [002] 63 Nuvion 63 cannabinor 63 ProSavin 63 ATACAND 63 Romidepsin 63 AGILECT R 63 diabetic neuropathic pain 63 Arikace 63 bazedoxifene 63 Panitumumab 63 Raptiva R 63 oral methylnaltrexone 63 PRX # 63 Targretin 63 Pegloticase 63 Ceflatonin ® 63 Glufosfamide 63 adipiplon 63 Posiphen 63 JANUVIA 63 velafermin 63 Phase IIIb clinical 63 INTEGRILIN 63 investigational humanized monoclonal antibody 63 IMiDs 63 Civacir 63 Icatibant 63 acyclovir Lauriad R 63 Canvaxin 63 Chrysalin 63 severe hypercholesterolemia 63 baminercept 63 OvaRex ® MAb 63 L BLP# 63 Elesclomol 63 Dapagliflozin 63 DCCR 63 MNTX 63 ISTODAX 63 GALNS 63 Tekamlo 63 Talabostat 63 Fodosine 63 SinuNase 63 lumiliximab 63 AZILECT ® 63 lurasidone 63 vosaroxin 63 Onbrez Breezhaler 63 atrasentan 63 Zalbin 63 PEGylated interferon beta 1a 63 CCX# 63 HoFH 63 vorinostat 63 selective modulator 63 reslizumab 63 SAR# [002] 63 posaconazole 63 OncoVEX GM CSF 63 oral FTY# 63 torezolid phosphate 63 nitazoxanide 63 Allovectin 7 ® 63 SUVN 63 AVE# 63 Rotigotine 63 LATUDA 63 MERLIN TIMI 63 elvucitabine 63 Ophena TM 63 Phase IIb clinical trials 63 Jevtana 63 Guanilib 63 dirucotide MBP# 63 albiglutide 63 bifeprunox 63 SNT MC# 63 ULORIC 63 JAK Inhibitor 63 TriRima 63 AVASTIN 63 erlotinib Tarceva 63 JANUMET 63 desvenlafaxine succinate 63 Phase 2a trial 63 VAPRISOL 63 IAP inhibitors 63 pertuzumab 63 sorafenib Nexavar 63 oral antidiabetic 63 teriflunomide 63 EOquin TM 63 Stedivaze 63 inhibitor RG# 63 pradefovir 63 Insegia 63 Aviptadil 63 romiplostim 63 investigational drug 63 Fampridine SR 63 AQ4N 63 Raptiva ® 63 Relivar 63 FOLOTYN ® 63 ATL# [002] 63 faropenem 63 ARIMIDEX 62 ONCONASE R 62 Nexavar ® 62 alagebrium 62 Octreolin 62 NV1FGF 62 DermaVir Patch 62 febuxostat 62 neratinib 62 PhosLo 62 LEVADEX ™ 62 Naproxcinod 62 Vidofludimus 62 LymphoStat B TM 62 liposomal formulation 62 olaparib 62 HCV protease inhibitor 62 DU #b 62 Randomized Phase 62 rhMBL 62 EVIZON TM 62 EOquin 62 milnacipran 62 TYSABRI natalizumab 62 Atrasentan 62 sorafenib tablets 62 Albugon 62 Phase IIb trials 62 vandetanib 62 phase Ib 62 AEG# 62 SinuNase TM 62 ATL/TV# 62 rilonacept 62 Valortim 62 EXPAREL TM 62 RhuDex R 62 Protexia R 62 octreotide acetate 62 orally administered 62 temsirolimus 62 telbivudine 62 docetaxel Taxotere R 62 Zoraxel 62 dose cohort 62 Vidaza azacitidine 62 IRX 2 62 Cloretazine ® 62 Onalta 62 volociximab 62 Ocrelizumab 62 ruboxistaurin 62 APD# 62 ALN PCS 62 Unit Dose Budesonide 62 UVIDEM 62 MAXY alpha 62 dexanabinol 62 Ambrisentan 62 PF # [002] 62 Xerecept 62 OPAXIO 62 Tezampanel 62 Cetrorelix 62 alemtuzumab treated 62 docetaxel Taxotere ® 62 LEUKINE 62 rilpivirine 62 BZL# 62 acting muscarinic antagonist 62 Orazol 62 regorafenib 62 zileuton 62 fampridine 62 pomalidomide 62 fosbretabulin 62 Apixaban 62 PDE# inhibitors 62 lesinurad 62 Riquent 62 Troxatyl 62 GGF2 62 tezampanel NGX# 62 hour bronchodilation 62 Virulizin R 62 Zolinza 62 Prodarsan ® 62 ATPace TM 62 MBP# [001] 62 Phase 1b trial 62 sitaxsentan 62 bendamustine 62 eniluracil 62 Pivotal Phase III 62 TKM ApoB 62 TH# [003] 62 angiogenesis inhibitor 62 Eltrombopag 62 Phase Ib II 62 dasatinib 62 APEX PD 62 Prosaptide 62 trastuzumab DM1 T DM1 62 enzastaurin 62 TNF antagonist 62 Amplimexon 62 Welchol 62 DXL# 62 albinterferon alfa 2b 62 bosutinib 62 Noxafil 62 ambrisentan 62 Santhera 62 tesofensine 62 novel VDA molecule 62 orally administered inhibitor 62 vascular disrupting agent 62 Sulonex 62 Davanat 62 PRISTIQ 62 hyperphenylalaninemia HPA due 62 GRN# 62 ixabepilone 62 PKC# 62 Ceflatonin R 62 MGd 62 systemically administered 62 PEG INTRON 62 AZILECT 62 Pazopanib 62 ThGRF 62 Campath alemtuzumab 62 synthetic retinoid 62 oral cladribine 62 targeted radiotherapeutic 62 davunetide intranasal AL 62 Adentri 62 ISENTRESS 62 Panzem 62 PF # [001] 62 erlotinib Tarceva ® 62 Azilect ® 62 HGS ETR2 62 eosinophilic asthma 62 Syncria 62 Milnacipran 62 adalimumab Humira 62 Cethrin 62 pharmacokinetic PK study 62 anticancer agent 62 antithrombotic 62 weekly subcutaneous injections 62 PhG alpha 1 62 Rilonacept 62 oral rivaroxaban 62 somatostatin analogue 62 Urocidin 62 CCX# B 62 rHuPH# 62 docetaxel chemotherapy 62 Phase IIa clinical trials 62 belinostat 62 OvaRex R 62 COREG CR 62 TYZEKA 62 NeuroSTAT ® 62 galiximab 62 BioNumerik 62 senicapoc 62 MYDICAR 62 darapladib 62 ADVANCE PD 62 ELACYT 62 Chemophase 62 Epothilones 62 RELOVAIR ™ 62 VA# [002] 62 IV Busulfex 62 BXT # 62 FTY# 62 tasimelteon 62 Aliskiren 62 GSK '# 62 nucleoside analog 62 visilizumab 62 Hycamtin 62 urocortin 2 62 palonosetron 62 IL# PE#QQR 62 tenofovir emtricitabine 62 evaluating tivozanib 62 Lixivaptan 62 ALN TTR 62 Phase 2a clinical 62 MGCD# [001] 62 dose limiting toxicities 61 Phase #/#a 61 terlipressin 61 HCD# [002] 61 acetylcholinesterase inhibitor 61 PrevOnco ™ 61 CDK inhibitor 61 beta 1a 61 Phase IIa trials 61 Initiate Phase 61 deforolimus 61 Candesartan 61 APTIVUS r 61 rindopepimut 61 APOPTONE 61 Neurodex 61 Fablyn 61 R roscovitine 61 Phase III Pivotal 61 Egrifta 61 aplindore 61 IPLEX 61 VGV 1 61 XL# XL# XL# XL# 61 Proellex TM 61 Ramoplanin 61 oral anticoagulant 61 Fx #A 61 mTOR inhibitor 61 DAVANAT 61 linaclotide 61 Certolizumab pegol 61 tolerated dose MTD 61 CK # 61 vidofludimus 61 Cimzia R 61 relapsed multiple myeloma 61 pramlintide 61 QT QTc 61 NATRECOR R 61 ocular formulation 61 RDEA# 61 Squalamine 61 EDEMA3 61 Proxinium TM 61 FASLODEX 61 KOMBIGLYZE XR 61 Combidex 61 relapsing remitting multiple sclerosis 61 castrate resistant prostate cancer 61 receptor tyrosine kinase inhibitor 61 panitumumab 61 USL# 61 IMiDs ® 61 sapacitabine 61 antidiabetic 61 Multiple Ascending Dose 61 Sanctura XR 61 Anavex #-# 61 cardiac toxicity 61 Beyond Advair 61 cinacalcet HCl 61 MYDICAR ® 61 Clofarabine 61 mGluR2 NAM 61 ORENCIA ® 61 RoACTEMRA 61 CIMZIA R 61 talabostat 61 maximally tolerated dose 61 Muraglitazar 61 Serdolect ® 61 dalfampridine 61 Ostarine 61 tesmilifene 61 ALTU 61 TMC# [002] 61 rhIGF-I/rhIGFBP-3 61 BAL# [002] 61 Acute Radiation Syndrome ARS 61 phase IIb trial 61 multicenter Phase II 61 sodium glucose cotransporter 61 drug GAP #B# 61 BLP# Liposome Vaccine 61 tolvaptan 61 anidulafungin 61 heterozygous FH 61 ThermoDox R 61 triphendiol 61 GFT# 61 entinostat 61 Nanobody ® 61 MEVACOR 61 cetuximab Erbitux 61 class mGluR5 inhibitor 61 Bevacizumab 61 Phase 2a Clinical Trial 61 figitumumab 61 Febuxostat 61 Dacogen decitabine 61 Dabigatran etexilate 61 Vimpat R 61 bortezomib Velcade 61 Vernakalant 61 TRIOLEX 61 RAPAFLO 61 valopicitabine 61 mGlu2 3 61 Urocortin 2 61 integrase inhibitor 61 Tocosol Paclitaxel 61 vemurafenib 61 SAR# [004] 61 CIMZIA TM certolizumab pegol 61 Junovan 61 ICA # 61 certolizumab pegol 61 GATTEX TM 61 quetiapine fumarate 61 Dual Opioid 61 Exelixis XL# 61 cilostazol 61 TLK# 61 PDX pralatrexate 61 diarrhea predominant irritable 61 REMINYL ® 61 Fampridine 61 Cloretazine R VNP#M 61 Viramidine 61 decitabine 61 Temsirolimus 61 Zenvia ™ 61 TRISENOX 61 Onco TCS 61 nonclinical studies 61 omecamtiv mecarbil 61 ACZ# 61 S/GSK# 61 trial evaluating PRX# 61 Varespladib 61 QVA# 61 telaprevir VX 61 incyclinide 61 Clolar ® 61 Glypromate 61 Campath ® 61 Sprycel dasatinib 61 Bafetinib 61 Personalized Immunotherapy 61 antiplatelet agent 61 tolevamer 61 Fibrillex 61 pegloticase 61 Alfimeprase 61 cilengitide 61 subcutaneous formulation 61 bardoxolone 61 BRIM3 61 pharmacological chaperone 61 Actemra tocilizumab 61 HGS ETR1 mapatumumab 61 Enzastaurin 61 SILENOR 61 active comparator 61 PEGINTRON TM 61 Valdoxan 61 oral taxane 61 zanolimumab 61 Herceptin trastuzumab 61 Androxal 61 Orphan Drug status 61 Ixabepilone 61 Zenapax 61 faropenem medoxomil 61 ZD# [001] 61 phase III isavuconazole 61 Certolizumab 61 RGB # 61 #ME# 61 Adalimumab 61 CANCIDAS 61 rufinamide 61 Phase #b/#a clinical 61 Ataluren 61 obatoclax 61 ruxolitinib 61 MyVax R 61 SILENOR TM 61 registrational trial 61 alefacept 61 Tolamba 61 pan HDAC inhibitor 61 small molecule Hedgehog 61 Excellarate TM 61 Phase 2b trial 61 vinca alkaloid 61 sargramostim 61 dasatinib Sprycel ® 61 Zelrix 61 Betaferon ® 61 Fibrin Pad 61 CBLC# 61 Phase III clinical 61 CCR5 mAb 61 TYGACIL 61 peginesatide 61 Iloperidone 61 Wellstat 61 relapsed MM 61 Phase IIb clinical 61 Phase #b/#a 61 PSN# [001] 61 DACH platinum 61 postoperative ileus POI 61 Lodotra 61 ACTEMRA 61 velafermin belinostat 61 prucalopride 61 VELCADE melphalan 61 PI3K/Akt pathway inhibitor 61 Anturol TM 61 Argatroban 61 REMOXY R 61 Gefitinib 61 placebo controlled Phase 61 AERx iDMS 61 Romiplostim 61 Increlex R 61 Azilect 61 PROVENGE sipuleucel T 61 Altastaph 61 refractory chronic lymphocytic 61 investigational protease inhibitor 61 Omnitarg 61 Revlimid lenalidomide 61 dyskinesia PD LID 61 Altropane 61 nilotinib 61 GED aPC 61 SGS# 61 VEGF Trap 61 Cinquil 61 Genasense ® 61 Cycloset 61 placebo controlled clinical 61 SCH # 61 lorvotuzumab mertansine 61 long acting muscarinic 61 integrin inhibitor 61 adecatumumab 61 Revimmune 61 frovatriptan 61 Nasulin 61 Lenalidomide 61 pharmacodynamic properties 61 IMA# 61 Epanova 60 levodopa carbidopa 60 nicotinic alpha 7 60 gepirone ER 60 Sebivo 60 Gattex 60 MAXY G# 60 pitavastatin 60 Investigational Compound 60 gabapentin enacarbil 60 immunomodulatory therapy 60 GAP #B# 60 HspE7 60 Kevetrin ™ 60 ZYBRESTAT 60 histone deacetylase HDAC inhibitor 60 serotonin norepinephrine reuptake inhibitor 60 bevacizumab Avastin ® 60 CYT# 60 Harbor BioSciences 60 glucokinase activator 60 Interferon alpha 60 NKTR 60 Æterna Zentaris 60 TNF Tumor Necrosis Factor 60 oxypurinol 60 Elvitegravir 60 Leukine 60 thrombolytic agent 60 nalbuphine ER 60 DP b# 60 Tesetaxel 60 Arcalyst 60 blinded randomized placebo controlled 60 chronic HCV infection 60 pharmacokinetic PK profile 60 Alinia 60 SARMs 60 Pralatrexate 60 virus HCV protease inhibitor 60 Abiraterone acetate 60 Promacta 60 Lubiprostone 60 Phase 1b 60 lixisenatide 60 fenofibric acid 60 HEPLISAV 60 chemopreventive agent 60 investigational monoclonal antibody 60 Navelbine ® 60 AzaSite Plus 60 therapeutic monoclonal antibody 60 davalintide 60 thalidomide Thalomid 60 novel oral anticoagulant 60 Horizant 60 SomatoKine 60 XL# XL# XL# 60 Darusentan 60 CCR9 antagonist 60 AMEVIVE 60 elagolix 60 Anticalin R 60 homotaurine 60 HER2 positive metastatic breast 60 anti amnesic 60 CORT # 60 GRNCM1 60 cMET 60 RSD# oral 60 Phase #b/#a trial 60 Nexavar sorafenib 60 bafetinib 60 Vitaxin 60 aclidinium bromide 60 Cariprazine 60 MEK inhibitors 60 Firazyr 60 REMICADE ® 60 BENLYSTA ® 60 GLYX 60 low dose cytarabine 60 metformin HCl 60 ranolazine 60 eculizumab 60 pseudobulbar affect PBA 60 ELADUR 60 Entereg R 60 Neuradiab 60 AA amyloidosis 60 generation purine nucleoside 60 Loxapine 60 Dacogen injection 60 azacitidine 60 nucleotide analogue 60 oxymorphone ER 60 metreleptin 60 Teriparatide 60 Factor VIIa 60 Melphalan 60 Excellarate 60 Cimzia TM 60 GA GCB 60 Stalevo 60 Ecallantide 60 ADP receptor antagonist 60 Intravenous CP 60 Palifosfamide 60 latrepirdine 60 ONGLYZA 60 Vandetanib 60 TOCOSOL Camptothecin 60 Afatinib 60 SNRI 60 CCR5 antagonist 60 indacaterol 60 Oglemilast 60 gemcitabine Gemzar ® 60 interferon beta therapy 60 cathepsin K inhibitor 60 delafloxacin 60 sitagliptin 60 K ras mutations 60 IMC #B 60 compound INCB# 60 rolofylline 60 RRMS patients 60 Valsartan 60 Resten NG 60 LT NS# 60 Phase 1b clinical 60 Bucindolol 60 Satraplatin 60 GV# [001] 60 ospemifene 60 Phase Ib IIa 60 Belinostat 60 molecular chaperone regulator 60 iSONEP 60 anti CD3 antibody 60 Menerba 60 postoperative ileus 60 Clavis Pharma 60 Betaferon R 60 OncoGel 60 Tocilizumab 60 Phase 2a 60 ganaxolone 60 Specifid 60 ApoB SNALP

Back to home page